Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience

SIMPLE SUMMARY: Hepatocellular cancer is the most common type of primary liver cancer. It is the third leading cause of cancer-related deaths worldwide and its incidence is increasing: >1 million new cases per year expected by 2025. Despite advances in treatment in recent years, diagnosis is asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinner, Friedrich, Pinter, Matthias, Scheiner, Bernhard, Ettrich, Thomas Jens, Sturm, Niklas, Gonzalez-Carmona, Maria A., Waidmann, Oliver, Finkelmeier, Fabian, Himmelsbach, Vera, De Toni, Enrico N., Ben Khaled, Najib, Mohr, Raphael, Fründt, Thorben Wilhelm, Kütting, Fabian, van Bömmel, Florian, Lieb, Sabine, Krug, Sebastian, Bettinger, Dominik, Schultheiß, Michael, Jochheim, Leonie S., Best, Jan, Müller, Christian, Keitel, Verena, Venerito, Marino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737362/
https://www.ncbi.nlm.nih.gov/pubmed/36497447
http://dx.doi.org/10.3390/cancers14235966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737362/
https://www.ncbi.nlm.nih.gov/pubmed/36497447
http://dx.doi.org/10.3390/cancers14235966

Ejemplares similares